Biosensor Startup Delta Diagnostics Sees Cash Injection

Biosensor research and development startup Delta Diagnostics has received a seed investment from The Netherlands Organization for Applied Scientific Research (TNO) and PhotonDelta, an ecosystem of photonic chip technology organizations. The investment primes the startup to further develop and validate its biosensor systems in preparation for a Series A investment round later this year.

Focused on instrumentation for life science research and diagnostic test development, Delta Diagnostics was spun out of TNO’s optics department in 2018 following a decade of related research. The company’s biosensor technology uses photonic chips to detect up to 16 biomolecules simultaneously.

According to co-founder and CTO Bart de Boer, “The next step is to move from prototype to serial producible product.” He and his team believe the technology will realize more reliable diagnostic tests that can be produced quickly and inexpensively.